1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. News
  7. Summary
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
Delayed Australian Stock Exchange  -  02:10 2022-07-05 am EDT
33.52 AUD   +0.45%
06/20SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/15SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/14SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sonic Healthcare : Application for quotation of securities - SHL

04/11/2022 | 03:59am EDT

Announcement Summary

Entity name

SONIC HEALTHCARE LIMITED

Announcement Type

New announcement

Date of this announcement

Monday April 11, 2022

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security

Number of +securities to

code

Security description

Issue date

SHL

ORDINARY FULLY PAID

142,500

11/04/2022

be quoted

Refer to next page for full details of the announcementPart 1 - Entity and announcement details

1.1 Name of entity

SONIC HEALTHCARE LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type ABN

1.3 ASX issuer code SHL

1.4 The announcement isNew announcement

1.5 Date of this announcement 11/4/2022

Registration number 24004196909

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class)

ASX +security code and description

SHLAK : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

TO (Existing Class)

ASX +security code and description

SHL : ORDINARY FULLY PAID

Please state the number of options

The first date the options were

The last date the options were

that were exercised or other

exercised or other +convertible

exercised or other +convertible

+convertible securities that were

securities were converted

securities were converted

converted

11/4/2022

11/4/2022

142,500

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying securities being received by the holder are:Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

No

Issue date 11/4/2022

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

Issue details

only

Number of +securities to be quoted 142,500

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid?

AUD - Australian Dollar

What is the issue price per +security?

AUD 34.80000000

For personal use

Any other information the entity wishes to provide about the +securities to be quoted

The amount of cash consideration paid for the 142,500 shares to be issued varies based upon the exercise price of the options that are being exercised.

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Sonic Healthcare Limited published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 07:58:05 UTC.


© Publicnow 2022
All news about SONIC HEALTHCARE LIMITED
06/20SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/15SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/14SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/10SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/08SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
06/06SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
05/30SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
05/24SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
05/23SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/27SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
More news
Financials
Sales 2022 9 215 M 6 313 M 6 313 M
Net income 2022 1 417 M 971 M 971 M
Net Debt 2022 1 201 M 823 M 823 M
P/E ratio 2022 11,4x
Yield 2022 2,97%
Capitalization 15 743 M 10 785 M 10 785 M
EV / Sales 2022 1,84x
EV / Sales 2023 2,05x
Nbr of Employees 38 000
Free-Float 95,4%
Chart SONIC HEALTHCARE LIMITED
Duration : Period :
Sonic Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SONIC HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 33,37 AUD
Average target price 37,53 AUD
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Colin Stephen Goldschmidt Chief Executive Officer, MD & Executive Director
Christopher David Wilks CFO, Finance Director & Executive Director
Mark R. Compton Chairman
Louis James Panaccio Independent Non-Executive Director
Kathryn Dianne Spargo Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SONIC HEALTHCARE LIMITED-28.44%10 785
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-20.58%6 149
SYNLAB AG-28.76%3 863
DR. LAL PATHLABS LIMITED-42.47%2 302
NOVOGENE CO., LTD.-29.39%1 742
FULGENT GENETICS, INC.-44.81%1 684